Health Canada has put all Drug Establishment License (DEL) holders on alert as to their regulatory responsibilities and obligations for maintaining good manufacturing practices (GMP).  In addition to increasing the frequency of planned and unplanned inspections of pharmaceutical manufacturing plants, Health Canada now offers a routinely updated and publicly available online tool for tracking the latest regulatory actions against drug manufacturing companies.  The “Inspection Tracker: Drug Manufacturing Establishments” provides a “snapshot of the potential health and safety issues that Health Canada is tracking with companies that fabricate, package/label, test, wholesale, distribute, or import drugs for sale in Canada.”   In response to allegations of inadequacy and secrecy, Health Canada has now made available the results of its pharmaceutical manufacturing plant inspections since 2012.

Source:  Toronto Star,  6 March 2015

Be Sociable, Share!

Leave a Reply